Bioethical Considerations in Telehealth Enabled Clinical Trials, An Interdisciplinary Discussion

The decentralized nature of telehealth enabled trials creates a different set of regulatory and ethical considerations compared to traditional, centralized trials. This expert panel will discuss these considerations from four different perspectives: clinical researcher, legal, bioethics professional, and participant/patient.


  • Moderator: Tufia Haddad, MD – Co-Chair, ATA Therapeutics Lifecycle SIG and Chair, Practice Innovation and Platform, Mayo Clinic Comprehensive Cancer Center; Medical Director of Care at Home, Center for Digital Health, Mayo Clinic
  • Michelle McGowan, MD, Professor of Biomedical Ethics
  • Shaalan Beg, MD – Vice President, Oncology, Science 37
  • Kyle Faget – Partner and Co-Chair, Health Care Practice Group, Foley & Lardner
  • Paul Melmeyer – VP, Public Policy and Advocacy, Muscular Dystrophy Association